Concepedia

David Gervais

DG

15

Publications

554

Citations

13

H-Index

1994

Active since

Affiliations

Defence Science and Technology Laboratory(Current)

Pfizer (United States)

Pfizer (Canada)

Public Health England

Institute of Structural and Molecular Biology

David Gervais is an author at Defence Science and Technology Laboratory specializing in medicine, microbiology, and engineering.

Top concepts

MedicineEngineeringMicrobiologyBiotechnologyAllergyImmunologyVaccinationBiochemistryBiomanufacturingNatural Sciences

Publications per year

1994–2021

15

Publications

15

Neuropsychiatric Disturbances in Presumed Late-Onset Cobalamin C Disease

Emmanuel Roze, David Gervais, Sophie Demeret et al. · Archives of Neurology · 2003 · 99 citations

Protein deamidation in biopharmaceutical manufacture: understanding, control and impact

David Gervais · Journal of Chemical Technology & Biotechnology · 2015 · 81 citations · Full text

Protein Chemistry, Biomanufacturing, Deamidation Reactions +15

Selection of a Novel Anti-Nicotine Vaccine: Influence of Antigen Design on Antibody Function in Mice

David C. Pryde, Lyn H. Jones, David Gervais et al. · PLoS ONE · 2013 · 80 citations · Full text

Novel Anti-nicotine Vaccine, Immunology, Immunodominance +23

Enhancing immunogenicity of a 3′aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates

Michael J. McCluskie, David C. Pryde, David Gervais et al. · International Immunopharmacology · 2013 · 57 citations

Vaccination, Vaccine Development, Allergy +13

Anti-nicotine vaccines: Comparison of adjuvanted CRM 197 and Qb-VLP conjugate formulations for immunogenicity and function in non-human primates

Michael J. McCluskie, Jennifer M. Thorn, David Gervais et al. · International Immunopharmacology · 2015 · 42 citations

Vaccinology, Vaccination, Mucosal Vaccination +11

Rows per page

1–5 of 15